Market Cap : 5.52 B | Enterprise Value : 8.97 B | PE Ratio : At Loss | PB Ratio : 1.14 |
---|
NYSE:PRGO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NYSE:PRGO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Perrigo Co's average Accounts Receivable for the three months ended in Jun. 2022 was $715 Mil. Perrigo Co's Revenue for the three months ended in Jun. 2022 was $1,122 Mil. Hence, Perrigo Co's Days Sales Outstanding for the three months ended in Jun. 2022 was 58.15.
The historical rank and industry rank for Perrigo Co's Days Sales Outstanding or its related term are showing as below:
During the past 13 years, Perrigo Co's highest Days Sales Outstanding was 109.23. The lowest was 54.96. And the median was 82.22.
PRGO's Days Sales Outstanding is ranked better thanPerrigo Co's Days Sales Outstanding declined from Jun. 2021 (58.65) to Jun. 2022 (58.15).
The historical data trend for Perrigo Co's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Perrigo Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Perrigo Co's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Perrigo Co's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Accounts Receivable can be measured by Days Sales Outstanding.
Perrigo Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2021 is calculated as
Days Sales Outstanding (A: Dec. 2021 ) | |||||||||
= | Average Accounts Receivable | / | Revenue | * | Days in Period | ||||
= | ( (Accounts Receivable (A: Dec. 2020 ) | + | Accounts Receivable (A: Dec. 2021 )) | / | count ) | / | Revenue (A: Dec. 2021 ) | * | Days in Period |
= | ( (593.5 | + | 652.9) | / | 2 ) | / | 4138.7 | * | 365 |
= | 623.2 | / | 4138.7 | * | 365 | ||||
= | 54.96 |
Perrigo Co's Days Sales Outstanding for the quarter that ended in Jun. 2022 is calculated as:
Days Sales Outstanding (Q: Jun. 2022 ) | |||||||||
= | Average Accounts Receivable | / | Revenue | * | Days in Period | ||||
= | ( (Accounts Receivable (A: Mar. 2022 ) | + | Accounts Receivable (A: Jun. 2022 )) | / | count ) | / | Revenue (A: Jun. 2022 ) | * | Days in Period |
= | ( (679.3 | + | 750.3) | / | 2 ) | / | 1121.7 | * | 365 / 4 |
= | 714.8 | / | 1121.7 | * | 365 / 4 | ||||
= | 58.15 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Thank you for viewing the detailed overview of Perrigo Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Ives Alison | officer: EVP & Chief Scientific Officer | C/O PERRIGO COMPANY PLC 515 EASTERN AVENUE ALLEGAN MI 49010 |
Hanson Kyle | officer: EVP & General Counsel | |
Bezerra Eduardo Guarita | officer: EVP & Chief Financial Officer | C/O FRESH DEL MONTE PRODUCE INC. PO BOX 149222 CORAL GABLES FL 33134 |
Ashford Orlando D | director | C/O AMERANT BANK 220 ALHAMBRA CR. CORAL GABLES FL 33134 |
Doyle Katherine C. | director | 100 ABBOTT PARK ROAD, AP6C-1N D032L ABBOTT PARK IL 60064 |
Sorota Richard S | officer: EVP & President CSCA | HARMAN INTERNATIONAL INDUSTRIES, INC. 1101 PENNSYLVANIA AVE, NW, #1010 WASHINGTON DC 20004 |
Mann Erica L | director | ONE KELLOGG SQUARE P.O. BOX 3599 BATTLE CREEK MI 49016-3599 |
Silcock Raymond | officer: EVP, Chief Financial Officer | 399 JEFFERSON ROAD PARSIPPANY NJ 07054 |
Willis Robert | officer: Acting CHRO | C/O PERRIGO COMPANY PLC 515 EASTERN AVENUE ALLEGAN MI 49010 |
Dillard James E Iii | officer: EVP, Chief Scientific Officer | 6601 WEST BROAD STREET RICHMOND VA 23230 |
Kessler Murray S | director, officer: CEO | 714 GREEN VALLEY ROAD GREENSBORO NC 27408 |
Smith Jeffrey C | director | 777 THIRD AVENUE, 18TH FLOOR NEW YORK NY 10017 |
Roehrhoff Uwe | director, officer: CEO | C/O PERRIGO COMPANY PLC TREASURY BUILDING, LOWER GRAND CANAL ST DUBLIN L2 D2 |
Classon Rolf A | director | C/O CATALENT, INC. 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 |
Karaboutis Adriana | director | C/O BIOGEN IDEC INC. 225 BINNEY ST. CAMBRIDGE MA 02142 |
From GuruFocus
By PRNewswire 11-02-2021
By PRNewswire 08-03-2021
By PRNewswire 04-04-2022
Other Sources
By Zacks 2022-02-09
By Seekingalpha 2021-12-16
By Zacks 2022-02-10
By Zacks 2022-02-21
By Fool 2021-11-10
By Zacks 2022-01-27
By Zacks 2022-03-31
By Zacks 2021-11-10
By Zacks 2021-11-08
By Seekingalpha 2022-01-09
By Zacks 2022-02-28
By Zacks 2022-02-22
By Zacks 2022-02-15
By Zacks 2022-02-28